Metastatic Malignant Melanoma

Metastatic Malignant Melanoma - most related articles:

- Breast cancer drug Abraxane promising for malignant melanoma treatment - 10.2
- Skin cancer cases hit record high, UK - 9.7
- Vaccine hope for skin cancer sufferers - 8.4
- New treatment for melanoma shows shrinking of tumors - 8.1
- Melanoma skin cancer triggered by BRAF gene mutation - 7.2
- Biomarker test promising for melanoma early diagnosis - 7
- Ipilimumab demonstrates improved survival in metastatic melanoma - 6.4
- Melanomas may appear different than other moles - 6.2
- New drug for melanoma skin cancer patients soon - 5.8
- New therapy promising for melanoma skin cancer - 5.5

Metastatic Malignant Melanoma articles

New treatment for melanoma shows shrinking of tumors
Researchers have made significant advances in the treatment of metastatic malignant melanoma – one of the most difficult cancers to treat successfully once it has started to spread.

Breast cancer drug Abraxane promising for malignant melanoma treatment
An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.

2 Metastatic Malignant Melanoma articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.58